Characterization of oxidative pathways in chronic rhinosinusitis and sinonasal polyposis

American Journal of Rhinology

Volumn 20, Issue 3, 2006, Pages 353-359

  Citardi, Martin J ^a   Song, Wei ^a   Batra, Pete S ^a   Lanza, Donald C ^b   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Sinus and Nasal Institute of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOLECULAR MARKER; NITRIC OXIDE; OXIDIZING AGENT; STEROID; TYROSINE;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC SINUSITIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASAL BIOPSY; NOSE MUCOSA; NOSE POLYP; OXIDATION; PROTEIN CROSS LINKING; PROTEIN MODIFICATION; RHINOSINUSITIS; TANDEM MASS SPECTROMETRY; TISSUE LEVEL; TURBINATE; VOLUNTEER;

ADULT; EOSINOPHILS; ETHMOID SINUS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MAXILLARY SINUS NEOPLASMS; MUCOUS MEMBRANE; NASAL POLYPS; PARANASAL SINUS DISEASES; POLYPS; TANDEM MASS SPECTROMETRY; TYROSINE;

EID: 33746130474     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2006.20.2858     Document Type: Article

References (12)

1. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: Bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg 99:S829-S848, 1997.
2. Mygind N, Dahl R, and Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax 55(suppl):S79-S83, 2000.
3. Carlson MG, Peterson CG, and Venge P. Human eosinophil peroxidase: Purification and characterization. J Immunol. 134:1875-1879, 1985.
4. Hazen SL, Zhang R, Shen Z, et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 85:950-958, 1999.
5. Mitra SN, Slungaard A, and Hazen SL. Role of eosinophil peroxidase in the origins of protein oxidation in asthma. Redox Rep 5:215-224, 2000.
6. Wu W, Chen Y, d'Avignon A, et al. 3-Bromo-tyrosine and 3,5-dibromo-tyrosine are major products of protein oxidation by eosinophil peroxidase: Potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 38:3538-3548, 1999.
7. Wu W, Chen Y, and Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274:25933-25944, 1999.
8. Brennan ML, Wu L, Fu X, et al. A tale of two controversies: Defining both the role of peroxidases in nitro-tyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277:17415-17247, 2002.
9. Wu W, Samoszuk MK, Comhair SA, et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 105:1455-1463, 2000.
10. Macpherson JC, Comhair AA, Erzurum SC, et al. Eosinophils are a major source of nitric oxicd-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 166:5763-5772, 2001.
11. Brennan ML, Anderson MM, Shih DM, et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 107:419-430, 2001.
12. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 129(suppl 3):S1-S32, 2003.